Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience
Nazaryan H, Liu Y, Sirotich E, Duncan J, Arnold D. Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience. Blood 2019, 134: 2120. DOI: 10.1182/blood-2019-128336.Peer-Reviewed Original ResearchSecond-line therapySecond-line treatmentImmune thrombocytopeniaTreatment start dateTPO-RAsEarly second-line therapyTreatment sequenceCommon treatment sequencesProspective longitudinal registryTherapy-associated toxicitiesRetrospective cohort studyFirst-line therapyProportion of patientsSecondary immune thrombocytopeniaSequence of therapyThrombopoietin receptor agonistsReal-world experienceCanadian academic centersLarge Canadian academic centerBristol-Myers SquibbSequence of treatmentImmunosuppressant medicationsOrder of treatmentTPO-RACohort study